Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Omnicell, Inc. | OMCL | 49.04K | $2.04M |
Hims & Hers Health, Inc. | HIMS | 49.45K | $1.71M |
United Therapeutics Corporation | UTHR | 49.99K | $27.09M |
Celcuity Inc. | CELC | 52.16K | $5.46M |
Stryker Corporation | SYK | 56.64K | $17.83M |
Waters Corporation | WAT | 59.83K | $22.44M |
Penumbra, Inc. | PEN | 60.22K | $19.01M |
Mineralys Therapeutics, Inc. | MLYS | 62.42K | $1.68M |
iRhythm Technologies, Inc. | IRTC | 65.2K | $7.76M |
Teleflex Incorporated | TFX | 79.71K | $10.1M |
Abbott Laboratories | ABT | 82.23K | $7.46M |
Hinge Health, Inc. | HNGE | 82.86K | $6.88M |
UnitedHealth Group Incorporated | UNH | 88.28K | $36.69M |
Gilead Sciences, Inc. | GILD | 90.86K | $11.48M |
Humana Inc. | HUM | 94.38K | $37.49M |
Denali Therapeutics Inc. | DNLI | 100.97K | $2.6M |
Rhythm Pharmaceuticals, Inc. | RYTM | 101.55K | $11.28M |
Omada Health | OMDA | 114.44K | $2.51M |
Syndax Pharmaceuticals, Inc. | SNDX | 118.42K | $2.59M |
Dianthus Therapeutics, Inc. | DNTH | 121.22K | $11.82M |